Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and L-Carnitine in Idiopathic Oligoasthenoteratozoospermia
NCT07669402Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2023
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole, levocarnitine in idiopathic oligoasthenoteratozoospermia (iOAT), sponsored by Tehran University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
letrozolelevocarnitine
03
Conditions
idiopathic oligoasthenoteratozoospermia (iOAT)
Beyond the preview
Go deeper on NCT07669402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07669402.